We are looking for children aged 2 to 17 years to join a clinical research study to help us discover more about treating moderate to severe ulcerative colitis. If you are looking for a potential new treatment option for moderate to severe ulcerative colitis or moderate to severe Crohn’s disease (including associated symptoms such as cramping, fever, rectal pain, weight loss and/or liver disease), consider one of our IBD studies. All eligible participants will receive no-cost study-related care and study medication. Your children aged 2 to 17 years may be eligible to take part.
Your child may be eligible to take part in the IBD studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Find out if your child may be able to to join.
